| __timestamp | Soleno Therapeutics, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 2917513 | 91733000 |
| Thursday, January 1, 2015 | 7878291 | 87644000 |
| Friday, January 1, 2016 | 8366794 | 92365000 |
| Sunday, January 1, 2017 | 6610381 | 85656000 |
| Monday, January 1, 2018 | 6556000 | 88196000 |
| Tuesday, January 1, 2019 | 6930000 | 89971000 |
| Wednesday, January 1, 2020 | 8758000 | 93413000 |
| Friday, January 1, 2021 | 10806000 | 91355000 |
| Saturday, January 1, 2022 | 9844000 | 113676000 |
| Sunday, January 1, 2023 | 13481000 | 198366000 |
| Monday, January 1, 2024 | 218935000 |
Cracking the code
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. From 2014 to 2023, Soleno Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. have shown contrasting approaches. Soleno's SG&A expenses have grown by approximately 362%, from $2.9 million in 2014 to $13.5 million in 2023. Meanwhile, Taro's expenses have more than doubled, reaching nearly $198 million in 2023, up from $91.7 million in 2014.
While Taro's expenses are significantly higher, reflecting its larger scale, Soleno's rapid increase suggests a strategic investment in growth. However, the absence of data for Soleno in 2024 leaves room for speculation. As the industry evolves, these companies' ability to manage SG&A costs will be pivotal in maintaining competitive advantage and ensuring sustainable growth.
Eli Lilly and Company vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Novo Nordisk A/S or Taro Pharmaceutical Industries Ltd.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Johnson & Johnson vs Soleno Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Novartis AG or Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? Genmab A/S or Taro Pharmaceutical Industries Ltd.
Summit Therapeutics Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
BioMarin Pharmaceutical Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Perrigo Company plc vs Soleno Therapeutics, Inc. Trends and Insights
ImmunityBio, Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Ligand Pharmaceuticals Incorporated and Soleno Therapeutics, Inc.
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Selling, General, and Administrative Costs: Taro Pharmaceutical Industries Ltd. vs Xencor, Inc.